(Press-News.org) A University of Colorado Cancer Center study being presented at the San Antonio Breast Cancer Symposium shows that triple negative breast cancer cells process tryptophan to promote survival while traveling through the body in order to seed new tumor sites.
"I'm not saying that people with metastatic breast cancer shouldn't eat turkey during the holidays, but triple-negative breast cancer appears to have found a way to process tryptophan more quickly, equipping cancer cells to survive while in circulation, which allows them to metastasize," says Thomas Rogers, the paper's first author and PhD candidate in the laboratory of CU Cancer Center investigator, Jennifer Richer, PhD.
When healthy cells become detached from the foundation on which they grow, they are programmed to undergo cell death through a process known as anoikis ("without a home" in Greek). This means that in order to metastasize, cancer cells have to evade anoikis - they have to survive while in suspension, unattached from a foundation. The current study used a gene array to discover which genes were upregulated in triple negative breast cancer cells that were able to grow in suspension compared with cells that were still attached to a substrate.
"Basically, we asked what is different in cells that are able to survive being detached," Rogers says.
Many of the gene expression changes in the triple negative breast cancer cells that had learned to survive detachment were in a single metabolic pathway - the kynurenine pathway, which is responsible for degrading the essential amino acid tryptophan. The faster the kynurenine pathway, the faster tryptophan is degraded. Controlling the speed of the kynurenine pathway is the enzyme TDO2 - which happened to be the most upregulated gene in detached compared to attached triple-negative breast cancer cells.
In other words, it may be that cancer cells over-express TDO2, which speeds up the whole kynurenine pathway, and degrades more tryptophan - all of which helps these cells to escape anoikis, which allows them to survive long enough to pick up roots and move to other places in the body.
"When a cancer cell detaches and cranks up this catabolic pathway, it can metabolize tryptophan faster and promote survival," Rogers says.
Currently, drugs targeting other enzymes in the complex chain of the kynurenine pathway are already in clinical trials. For example the drug indoximod by New Link Genetics is being tested in combination with chemotherapy against metastatic breast cancer (clinicaltrials.gov number NCT01792050). This drug adjusts features within the pathway to help the body's immune system more effectively target cancer cells.
"We hope that looking at other targets in this pathway could create a more effective therapy," Rogers says. "Indoximod or other compounds like it could be used in combination to not only boost the immune system to target free-floating cancer cells, but also to re-sensitize cancer cells to the programmed cell death of anoikis."
INFORMATION:
DALLAS - Dec. 10, 2014 - UT Southwestern Medical Center microbiologists have identified key bacteria in the gut whose resources are hijacked to spread harmful foodborne E. coli infections and other intestinal illnesses.
Though many E. coli bacteria are harmless and critical to gut health, some E. coli species are harmful and can be spread through contaminated food and water, causing diarrhea and other intestinal illnesses. Among them is enterohemorrhagic E. coli or EHEC, one of the most common foodborne pathogens linked with outbreaks featured in the news, including ...
An anomaly spotted at the Large Hadron Collider has prompted scientists to reconsider a mathematical description of the underlying physics. By considering two forces that are distinct in everyday life but unified under extreme conditions like those within the collider and just after the birth of the universe, they have simplified one description of the interactions of elementary particles. Their new version makes specific predictions about events that future experiments at the LHC and other colliders should observe and could help to reveal "new physics," particles or processes ...
BERKELEY -- Future fitness trackers could soon add blood-oxygen levels to the list of vital signs measured with new technology developed by engineers at the University of California, Berkeley.
"There are various pulse oximeters already on the market that measure pulse rate and blood-oxygen saturation levels, but those devices use rigid conventional electronics, and they are usually fixed to the fingers or earlobe," said Ana Arias, an associate professor of electrical engineering and computer sciences and head of the UC Berkeley team that is developing a new organic optoelectronic ...
New Haven, Conn. - A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented at the 2014 San Antonio Breast Cancer Symposium, held Dec. 6-9, by Kerin Adelson, M.D., assistant professor of medical oncology at Yale Cancer Center and chief quality officer at Smilow Cancer Hospital at Yale-New Haven.
The trial enrolled 118 post-menopausal women with metastatic hormone-receptor-positive breast cancer ...
PHILADELPHIA--Two-thirds of women treated for early-stage breast cancer in the U.S. receive longer radiation therapy than necessary, according to a new study published in JAMA this week from Penn Medicine researchers Ezekiel J. Emanuel, MD, PhD, and Justin E. Bekelman, MD. Their findings reveal that the vast majority of women after breast conserving surgery receive six to seven weeks of radiation therapy, despite multiple randomized trials and professional society guidelines showing that three weeks of radiation - called hypofractionated whole breast radiation - is just ...
Although the use of a type of radiation treatment that is shorter in duration and less costly has increased among women with early-stage breast cancer who had breast conserving surgery, most patients who meet guidelines to receive this treatment do not, according to a study appearing in JAMA. The study is being released to coincide with the San Antonio Breast Cancer Symposium.
Breast cancer accounts for the largest portion of national expenditures on cancer care, estimated to reach $158 billion in 2020. Breast conservation therapy is the most common treatment for early-stage ...
Researchers at Case Western Reserve University School of Medicine have uncovered the mechanism that enables the enzyme Lecithin: retinol acyltransferase (LRAT) to store vitamin A--a process that is indispensable for vision.
"Without this information, our knowledge was inadequate to understand the molecular mechanisms of blindness caused by mutations in the enzyme," said Marcin Golczak, assistant professor of pharmacology at Case Western Reserve and an author of the study.
The researchers hope the new information will be used to design small molecule therapies for degenerative ...
New research reports that liver transplant recipients with less understanding of treatment information and improper use of medications may be more likely to have trouble following the prescribed regimen. According to the study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, the patients' non-adherence is linked to adverse clinical outcomes, such as organ rejection or graft loss.
During the past 30 years, improvements in surgical techniques and advances in immunosuppressive ...
Reductions in government healthcare spending in the European Union (EU) are associated with increased maternal mortality rates, suggests a new paper published today (10 December) in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG). However, if skilled birth attendants are in place, the association disappears, highlighting the potential importance of maternal care, finds the research.
The study looks at the association between reductions in government healthcare spending (GHS) and maternal mortality across the European Union (EU) over a 30 year period ...
WASHINGTON - The correlation between Internet searches on a regional medical website and next-day visits to regional emergency departments was "significant," suggesting that Internet data may be used in the future to predict the level of demand at emergency departments. The first study to use Internet data to predict emergency department visits in either a region or a single hospital was published online Friday in Annals of Emergency Medicine ("Forecasting Emergency Department Visits Using Internet Data") .
"Website visits may be used to predict ER visits for a geographic ...
